Additionally, compared with the control group, a majority of NFATc2 in SR HCC cells was localized in the nucleus, whereas deletion of STIM1 resulted in reduced nuclear localization of NFATc2 (Fig. 5G). This evidence concerns the gene NFATC2 and hepatocellular carcinoma.